In this episode of Behind the Insights, Carl D. Marci, MD, Chief Clinical Officer and Managing Director of Mental Health and Neuroscience at OM1, explores the complexities of Treatment-Resistant Depression (TRD) and how OM1’s AI-driven models are reshaping the way we identify and treat patients. Discover how real-world data, clinician attestation, and unstructured clinical notes are unlocking hidden patterns in mental health care, and what the future holds for AI in mental health.

0:00 Intro

0:37 What is Treatment-Resistant Depression and why is it so challenging to define and detect?

1:13 How common is it for patients to experience failure with multiple treatments?

1:43 Highlighting “psychiatrist-attested TRD” with AI and unstructured clinical notes

2:38 Can you walk us through how you know which definition of TRD is correct?

3:35 How do you see AI evolving in the discovery and treatment of TRD?

4:05 How do we ensure trust, accuracy, and clinical relevance when using AI to identify patients?

4:38 The future of mental health and AI

5:04 Final Thoughts

📩 Stay updated on future episodes: https://go.om1.com/l/1071043/2025-02-10/bk8151

🎯 Follow us! LinkedIn: https://www.linkedin.com/company/om1-inc./

Facebook: https://www.facebook.com/profile.php?id=61573205886660

X: https://x.com/Om1Inc

🌐 Visit our website: https://www.om1.com/

#mentalhealth #depression #treatmentresistantdepression #ai #realworlddata #rwd #realworldevidence #rwe #clinicalresearch #pharma